The reproductive performance of lactating dairy cows is a major factor affecting herd profitability, which means that calving intervals should be kept within a targeted timespan. To attain this goal, accurate and high percentage estrus detection are critically important \[[@r25]\]. The expression of estrus can be influenced by many different factors, such as heredity, the number of days postpartum, lactation number, milk production, nutrition, season, housing, herd size, and health \[[@r37]\]. Milk production per cow is increasing year on year, and herd sizes are getting larger \[[@r37]\]. A negative association between high milk production and the expression of behavioral estrus has been observed \[[@r11],[@r12],[@r13], [@r23], [@r27]\], and the percentage of standing estrus and the duration of estrus have decreased over the past 50 years \[[@r14], [@r51]\]. For these reasons, it is becoming difficult to accurately detect estrus. Inadequate or inaccurate detection of estrus are critical factors that are responsible for poor reproductive performance in dairy cows \[[@r37], [@r52]\].

To deal with this problem, several methods for estrous or ovulation synchronization have been devised \[[@r8], [@r26], [@r34]\]. A well-established method for estrous synchronization was to regress the corps luteum (CL) using prostaglandin F~2α~ or its analogue (PG) \[[@r26], [@r53]\]. However, a major problem with this method is the lack of a consistent time point to induce estrus \[[@r26]\], with the number of days from PG treatment to estrus varying from 2--9 days \[[@r30]\]. In addition, it has been reported that PG may fail to induce luteolysis or ovulation \[[@r47]\]. For these reasons, estrus synchronization cannot be used to predict when timed artificial insemination (TAI) needs to take place \[[@r2], [@r3], [@r53]\].

Subsequently, ovulation synchronization using PG and GnRH (Ovsynch) has been developed. The advantage of this method is that TAI can take place without estrous detection \[[@r8], [@r30], [@r34], [@r35], [@r52], [@r53]\]. However, Ovsynch needs to be initiated on Day 5 to 12 of the estrous cycle to be effective \[[@r31], [@r50], [@r52]\]. Otherwise, the conception rate after TAI is not high due to incomplete CL regression after PG treatment and poor ovulatory responses to GnRH \[[@r10], [@r28], [@r46], [@r49], [@r53]\]. Previous studies have reported using a pre-synchronization strategy to increase the conception rate by Ovsynch. In this method, cows receive two PG treatments 14 days apart and both are administered at least 14 days before the initiation of Ovsynch \[[@r8], [@r32], [@r46], [@r52]\]. The most important requirement for pre-synchronization is that the cows need to recover their ovarian activity after parturition \[[@r7], [@r16]\]. Ovsynch is known to induce cyclicity in a high percentage of anovular cows \[[@r16]\]. Therefore, Souza *et al*. replaced the pre-synchronization strategy used with Ovsynch and suggested a single method to increase fertility using TAI, which they called the Double-Ovsynch method \[[@r42]\]. However, Double-Ovsynch requires a long period of time from initiation to TAI, is expensive, and is labor intensive. This has indicated that no obvious economic benefit has been identified \[[@r43], [@r44]\].

Although estrous synchronization by luteolysis using PG is inconsistent, when PG treatment is followed by estrous detection, the conception rate tends to be higher \[[@r3], [@r4], [@r21]\]. The low conception rate in cows after TAI with PG is most likely related to the greater variation in the timing of ovulation following PG treatment \[[@r4]\]. If the time of ovulation can be predicted more correctly after PG treatment, estrous synchronization by PG will become more useful because it is simple and economical. In particular, it seems to be more suitable on farms where the herd size is not large. It has been suggested that the timing of PG treatment relative to stage that a follicular wave is in a major cause of variation in the subsequent onset of estrus or ovulation \[[@r40]\] and the type of ovulated follicle (1st, 2nd, or 3rd wave dominant follicle) \[[@r30]\]. Furthermore, ovulation does not occur in some cows, even when PG treatment induces apparently normal estrus \[[@r45]\]. In this study, we investigated the basic factors that affected the interval from PG treatment to ovulation and the type of ovulated follicle produced. We also attempted to clarify the reasons why PG treatment failed to induce ovulation.

MATERIALS AND METHODS {#s1}
=====================

Animals
-------

Nine Holstein cows (Cow numbers 1--9) were used per group. Their ages were \>4 years (5.8 ± 0.6; mean ± SD). The animals were housed in a tie-stall barn at Azabu University, Japan. None of these cows had been inseminated after their last parturition and had been milked because they were kept for educational purposes. The parities of the cows were unknown and ≥2 years had passed since their last parturition. Rectal examination of the cows confirmed that there were no clinical abnormalities of the uterus or any abnormal vulvar discharge. All experiments were carried out with approval from the Ethics Committee of Azabu University.

Ultrasound scanning
-------------------

A real-time ultrasonograph (Model HS-2100V; Honda Electronics Co., Ltd., Toyohashi, Japan) equipped with a 10-MHz transrectal linear transducer was used to monitor the daily changes in follicles and the CL between 11:00 and 14:00. Natural ovulation (Day 0) was defined as being when the DF appeared in the ovary at estrus and was confirmed to have disappeared by transrectal palpation and real-time ultrasonography. The 1st wave DF (1st DF) was the follicle that grew the largest after natural ovulation, and the 2nd wave DF (2nd DF) was the follicle that grew the largest after the 1st DF had regressed. The size of the follicle was the mean of the long diameter and short diameter.

Treatment with PG
-----------------

Nine cows were randomly assigned to six groups after natural ovulation until the number of cows in each group reached eight (or 48 cows in total actually tested). The cows in each group were administered PG (25 mg tromethamine dinoprost as dinoprost, Pronalgon F; Zoetis JP, Tokyo, Japan) intramuscularly on Day 6 (Group D6), Day 7 (Group D7), Day 8 (Group D8), Day 9 (Group D9), Day 10 (Group D10), or Day 11 (Group D11) after natural ovulation. After PG treatment, the ovaries were monitored from Day 1 to Day 18 and ovulation of the DF was confirmed. The cows were assigned into each group only one time. If both the 1st DF and the 2nd DF did not ovulate after PG treatment, then the cows were assigned into Group NO. We recorded the type of ovulated DF (1st DF or 2nd DF) and how many days it took to ovulate after PG treatment. The interval between each PG treatment was 47.9 ± 3.8 days (mean ± SEM, n=50), and the range was 27--163 days.

Blood sampling
--------------

A vacuum-type heparinized tube was used to collect each blood sample from the tail vein. The plasma was separated by centrifugation (3,500 × *g* for 10 min) and stored at −30°C until the progesterone (P~4~) and estradiol-17β (E~2~) concentrations in the plasma were determined.

Hormone analysis
----------------

The P~4~ concentrations in the plasma were determined using the enzyme immuno-assay (EIA) methods described previously \[[@r19]\]. The E~2~ levels in plasma were also measured using the EIA methods as described by Isobe \[[@r18]\], with some modifications. Briefly, 75 *µl* of extracted estradiol-17β standard or the sample and 25 *µl* of the 1:10,000 diluted estradiol-17β antibody (ab215528, Abcam, Cambridge, UK) were applied to the wells of plates that had been previously coated with goat anti-rabbit IgG antibody (Millipore; Merck & Co., Inc., Kenilworth, NJ, USA). After 1 hr incubation, 25 *µl* of 1:2,500 diluted estradiol-6-CMO-HRP antigen (East Coast Bio, Inc., North Berwick, ME, USA) was added to the wells. The plate was incubated for another hour and then washed six times. The substrate solution was applied to the wells, and then, they were incubated for 30 min at room temperature. The reaction was stopped by the addition of 1 M H~3~PO~4~. The optical density was calculated at 450 nm. Sensitivity was 1.6 *p*g/m*l* for E~2~ and 0.5 *n*g/m*l* for P~4~. The intra-assay and inter-assay CVs were 11.4% and 6.7% for E~2~ and 8.6% and 3.2% for P~4~, respectively.

Data analysis
-------------

We compared the number of days from PG treatment to ovulation, P~4~ from 1 day before to 3 days after PG treatment, E~2~ after PG treatment, and the size of the 1st DF among the groups (ANOVA followed by the Tukey-Kramer test). Furthermore, the incidence rate of anovulation in Group NO was compared among the individual cows and among the days when PG was administered (χ^2^ test followed by Fisher's exact test). The values are presented as the mean ± standard error of the mean and were considered to be statistically significant at the *P*\<0.05 level.

RESULTS {#s2}
=======

Ovulated DFs and the number of days from PG treatment to ovulation
------------------------------------------------------------------

Out of a total of 48 ovulated cases, 22 cases (45.8%), 16 cases (33.3%), 9 cases (18.8%), and 1 case (2.1%) ovulated 4 days, 5 days, 6 days, and 7 days after PG treatment, respectively.

The type of ovulated dominant follicle in each group is shown in [Table 1](#tbl_001){ref-type="table"}Table 1.Number of days from prostaglandin treatment to ovulation. In Group D6, the 1st DF ovulated in all cows. In Group D7 and Group D8, the 1st DF ovulated in four or five cows, and the ovulated DF was the same in seven cows. The results showed that there were four cows in which the 1st DF ovulated in Group D7 and Group D8. Again, there were three cows in which the 2nd DF ovulated in Group D7 and Group D8. In Groups D9, D10, and D11, the 2nd DF ovulated in all cows.

The relationship between the number of days from PG treatment to ovulation and the ovulated follicle is also shown in [Table 1](#tbl_001){ref-type="table"}. In cases when the 1st DF ovulated, all of them ovulated 4 days after PG treatment. In cases when the 2nd DF ovulated, ovulation occurred between 4--7 days after PG treatment. The number of days from PG treatment to the 2nd DF ovulation in Group D7 was the longest (6.0 ± 0.4; mean ± SEM). It decreased as the PG treatment day became later, and it was the shortest in Group D11 (4.9 ± 0.2). There were significant differences between the days when the 1st DF ovulated (*P*\<0.05) in the cases where the 2nd DF ovulated in Group D7 and Group D9.

Size of the 1st DF
------------------

The size of the 1st DF at PG treatment and 3 days after PG treatment in each group is shown in [Table 2](#tbl_002){ref-type="table"}Table 2.Size of 1st and 2nd dominant follicles (mm)Ovulated follicle1st DF at PG^c)^1st DF 3 days after PG2nd DF at PG (n)2nd DF before OV^d)^Group D612.2 ± 0.5^i)^15.5 ± 0.6^g,j)^――1st DF^a)^Group D713.2 ± 1.015.8 ± 1.2^g)^――Group D812.9 ± 1.014.8 ± 1.9^g)^――Group D712.0 ± 1.011.6 ± 0.4^h)^(0)12.4 ± 0.2Group D810.9 ± 0.810.6 ± 1.9^h)^6.0 (1)11.8 ± 1.12nd DF^b)^Group D914.0 ± 1.5^k)^10.0 ± 0.7^h,l)^8.3 ± 0.8 (3)13.2 ± 0.4Group D1014.1 ± 0.9^e,m)^10.1 ± 0.9^h,n)^7.5 ± 0.8 (2)^q)^12.8 ± 0.5Group D1111.6 ± 0.5^f,o)^7.9 ± 0.8^h,p)^9.2 ± 0.6 (5)^r)^13.3 ± 0.4AnovulationGroup NO12.5 ± 0.413.3 ± 0.9^g)^a) 1st wave dominant follicle. b) 2nd wave dominant follicle. c) Prostaglandin treatment. d) Ovulation. Data are expressed as means ± standard error. Groups with superscripts e and f; g and h; i and j; k and l; m and n; o and p; and q and r were significantly different from each other (*P*\<0.05).. Although the size of the 1st DF at PG treatment in Groups D9 and D10 tended to be large, there were no significant differences among the groups except for Group 11. The 1st DF in Group D11 was the smallest in size, and there were significant differences between Group D11 and Group D10. The sizes of the 1st DF at 3 days after PG treatment in the groups where the 1st DF ovulated and in Group NO were significantly larger than those in the groups where the 2nd DF ovulated. Furthermore, the size of the 1st DF in the groups where the 1st DF ovulated and in Group NO became larger 3 days later. However, the size of the 1st DF in the groups where the 2nd DF ovulated was smaller, and there were significant differences between the time of PG treatment and at 3 days later among Group D9, Group D10, and Group D11. The sizes of the 2nd DF at PG treatment and 1 day before ovulation in groups where the 2nd DF ovulated are also shown in [Table 2](#tbl_002){ref-type="table"}. The 2nd DF was not observed at PG treatment in many cows (20/31; 64.5%). Although the size of the 2nd DF tended to be larger as the day of PG treatment became later, there was no clear size tendency among any of the groups. Furthermore, there were no significant differences among the groups for the size of the 2nd DF at 1 day before ovulation

Incidence rates of anovulation
------------------------------

By the time all six groups had eight cows each, there were 10 cases in which neither the 1st DF nor the 2nd DF ovulated (10/58; 17.2%). The anovulation incidence rate was different among individuals. The highest rate was in Cow No. 2 (4/5; 80.0%), and it was significantly higher than in the other cows except for Cow No. 6 (*P*\<0.05) ([Table 3](#tbl_003){ref-type="table"}Table 3.Anovulation incidence ratesCow No.%PG day^a)^%Cow No. 114.3^c)^(1/7)Day 633.3^d)^(4/12)Cow No. 280.0^b)^(4/5)Day 720.0(2/10)Cow No. 30^c)^(0/6)Day 820.0(2/10)Cow No. 40^c)^(0/6)Day 911.1(1/9)Cow No. 514.3^c)^(1/7)Day 1011.1(1/9)Cow No. 637.5(3/8)Day 110^e)^(0/8)Cow No. 714.3^c)^(1/7)Cow No. 80^c)^(0/6)Cow No. 90^c)^(0/6)Total17.2(10/58)Total17.2(10/58)a) Day when prostaglandin was administrated. The values in the same column with different letters as superscripts are significantly different (*P*\<0.05). Groups with superscripts b and c; and d and e were significantly different from each other (*P*\<0.05).). Furthermore, the anovulation incidence rate was different among the days when PG was administered, and the earlier the day on which PG was administered, the higher the anovulation incidence rate. The highest rate was on Day 6 (4/12; 33.3%), and it was significantly higher than on Day 11 (*P*\<0.05) ([Table 3](#tbl_003){ref-type="table"}). Anovulated DFs maintained their size for a few days and then regressed, or they increased their size and became like cystic follicles. In those cases, a new DF did not develop very quickly.

Changes in P~4~ and E~2~
------------------------

The changes to P~4~ in each group from 1 day before to 3 days after PG treatment are shown in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Mean ± SEM P~4~ concentration between 1 day before and 3 days after PG treatment: Group D6 (●); Group D7 (×); Group D8 (○); Group D9 (□); Group D10 (▲); Group D11 (■); Group NO (Δ). PG, PG treatment. P~4~, progesterone.. The P~4~ level was more than 1 *n*g/m*l* at 1 day before and on the day of PG treatment in all groups. Although the levels tended to be higher as the day when PG was administered got later, there were no significant differences among the groups. The P~4~ levels decreased to less than 1 *n*g/m*l* on the day after PG treatment in all groups.

The changes to E~2~ in each group are shown in [Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Mean ± SEM E~2~ concentration after PG treatment: Group D6 (●); Group D7 (×); Group D8 (○); Group D9 (□); Group D10 (▲); Group D11 (■). Significant differences between groups: a-The E~2~ concentration at this time point for Group D6 is significantly different from all other groups; b-The E~2~ concentration at this time point for Group D6 was significantly different from all other groups; c-The E~2~ concentration at this time point for Group D7 was significantly different from all other groups; d-The E~2~ concentration at this time point for Group D8 was significantly different from all other groups; e-The E~2~ concentration at this time point for Group D9 was significantly different from Groups D7, D10, and D11; f-The E~2~ concentration at this time point for Group D10 was significantly different from Groups D7 and D8; g-The E~2~ concentration at this time point for Group D11 was significantly different from all other groups (*P*\<0.05).. The E~2~ levels fluctuated around 1 *p*g/m*l*, but then began to increase rapidly after PG treatment and peaked 2 days after PG treatment in Groups D6, D7, and D8. However, the peak occurred at 4 days after PG treatment in Group D9, and 3 days after PG treatment in Groups D10 and D11. The E~2~ peak occurred 2 days before ovulation in 40 out of 48 cows. [Figure 3](#fig_003){ref-type="fig"}Fig. 3.E~2~ concentration after PG treatment in Group NO. E~2~, estradiol-17β. shows the change in E~2~ after PG treatment in Group NO. Although E~2~ was around 1 to 2 *p*g/m*l* before PG treatment, it tended to increase and maintain a high value after PG treatment. Furthermore, there was no clear peak in some cows.

DISCUSSION {#s3}
==========

The type of follicle that ovulated and the number of days from PG treatment to ovulation were affected by the day when PG was administered. Ovulation did not occur in 10 cases. The factors that affected these results may be due to the CL, the follicle, or both. Furthermore, due to PG being administrated after natural ovulation following natural CL regression, and because the mean interval between each PG treatment was 47.9 days, it does not seem that repeated PG treatment affected the development of follicles or ovulation.

The range for the time to estrus is due in part to the difference in the regression rate of the CL among the cows after the PG treatment had been administered \[[@r4], [@r22], [@r52]\]. At natural ovulation, P~4~ decreases to below 1 mg/m*l*, and after 2--3 days, the CL begins to regress in parous cows \[[@r39]\]. However, because regression of the CL was induced by PG treatment in this study, P~4~ decreased to around 1 *n*g/m*l* or less in all groups the day after PG treatment, which was consistent with the findings in previous studies \[[@r17], [@r47], [@r48]\]. Furthermore, there were no differences between the P~4~ values before and after PG treatment among the groups, including Group NO. These results suggested that the CL factors could be eliminated.

The interval from PG treatment to ovulation is also related to the time required to develop an ovulatory follicle \[[@r4], [@r22]\]. When the P~4~ concentration in the blood decreases as a result of CL regression, the increased pulsatile secretion of gonadotropins causes the DF to mature and secrete E~2~ \[[@r4]\]. This resulting E~2~ elevation in the blood triggers a preovulatory LH surge within 12--20 hr \[[@r5], [@r9]\]. Ovulation occurs 30 hr after the LH surge \[[@r20]\], which means that ovulation will occur about 2 days after the elevation in E~2~. In this study, most ovulated cows had a clear E~2~ peak at 2 days before ovulation. The E~2~ peak in Groups D6, D7, and D8 occurred 2 days after PG treatment. The results showed that when a follicle that can immediately secret E~2~ exists, P~4~ decreases and E~2~ begins to rise on the day after PG treatment, E~2~ reaches a peak 2 days after PG treatment, and the follicle ovulates 4 days after PG treatment. This explains why all 1st DFs ovulated 4 days after PG treatment in this study. The results suggest that the interval from PG treatment to ovulation is related to the ability of the follicle to produce E~2~. The reason that the E~2~ peak occurred 3 or 4 days after PG treatment in Groups D9, D10, and D11 may be that the 1st DF lost its dominance and could not produce E~2~, but the 2nd DF may have taken some time to develop to the point where it could produce E~2~.

In Group D6, the 1st DF ovulated 4 days after PG treatment in all cows. However, the 1st DF did not ovulate in half of the cows in Groups D7 and D8, and in any cow in Group D9. This means that the 1st DF could not secrete enough E~2~ to induce the LH surge in half of the cows in Groups D7 and D8 or in any cow in Group D9, and that the 1st DF loss of dominance had occurred on Day 8 or Day 9. Although there were no differences in the sizes of the 1st DF at the time of PG treatment among any group other than Group D11, at 3 days after PG treatment, the 1st DF size had become larger in cows in which the 1st DF ovulated, but it had become smaller in cows in which the 2nd DF ovulated. This means that the 1st DF in cows in which the 2nd DF ovulated became atretic. Mihm *et al*. reported that the 1st DF loses its dominance between Day 6 and Day 8 \[[@r29]\], and Adams *et al*. reported that atresia of the 1st DF occurred between Day 8 and Day 9 \[[@r1]\]. When PG is administered to cows that have an atretic DF, then that particular DF cannot ovulate, and another follicle will develop and ovulate \[[@r17]\].

In Groups D7 and D8, the ovulated DF was the same in seven out of eight cows. This suggested that the time that atresia of the 1st DF begins was determined by the individual cow. Kastelic *et al*. reported that all heifers (6/6) in which the 1st DF ovulated when PG was administered on Day 8 had two wave estrous cycles \[[@r22]\]. In this study, the cows in which the 1st DF ovulated might have had two wave estrous cycles, and the cows in which the 2nd DF ovulated might have had three wave estrous cycles.

In cases where the 2nd DF ovulated, the ovulation occurred over 4--7 days after PG treatment, and the E~2~ peak occurred 2 days before ovulation. Furthermore, the number of days between PG treatment and ovulation decreased as the PG treatment day got later. This indicated that the time needed for the 2nd DF to acquire the ability to generate the peak E~2~ levels in order to induce the LH surge is affected by the day of PG treatment. The interval from PG treatment to estrus or the LH surge is related to the time required to develop an ovulatory follicle \[[@r4], [@r22]\], and the number of days from PG treatment to ovulation is affected by the degree of maturation of the 2nd DF at the time of PG treatment \[[@r20]\]. If the PG treatment was delayed until after Day 12, then the maturation stage of the 2nd DF at the time of PG treatment was more advanced and the number of days to ovulation of the 2nd DF after PG treatment approached 4 days, which was the same as for the 1st DF ovulation. However, the 2nd DF was not observed at PG treatment in many cows in this study. Previous studies have shown that the emergence of the 2nd DF does not occur until Day 8 to Day 10 \[[@r1]\]. Therefore, the number of days to ovulation of the 2nd DF after PG treatment cannot be predicted from the size of the 2nd DF when PG treatment is administered.

In this study, ovulation did not occur in 10 cases after PG treatment, and the next DF took some time to develop, which confirmed the results of previous studies \[[@r47]\]. In the cows in which ovulation did not occur, P~4~ decreased immediately, which was similar to the ovulated cows after PG treatment. However, some cows did not show the E~2~ peak that was seen in the ovulated cows after PG treatment. Increasing E~2~ and decreasing P~4~ after luteolysis stimulates the LH pulse frequency, which results in a large preovulatory LH surge \[[@r1]\]. This suggests that the LH surge might not have been induced in anovulated cows. Furthermore, E~2~ levels remained high in some anovulated cows compared to ovulated cows after PG treatment. Although the cause of this phenomenon is not known, it may be due to follicular E~2~ secretion problems. Cases where the DF did not ovulate occurred frequently in particular cows or when PG was administered on Day 6 or Day 7. Furthermore, when cows were injected with PG between Day 5 and Day 9, the response was worse than when the PG treatment was administered later in the cycle \[[@r52]\]. This suggested the existence of cows that cannot secrete E~2~ normally after PG treatment, or the existence of endocrine disturbance around the time when the dominance shifts from the 1st DF to the 2nd DF.

There are several methods that can be used to make TAI with PG a practical proposition. One way is to control the E~2~ concentration in the blood \[[@r15]\]. The potential and timing of ovulation by an existing DF after PG treatment depend on the E~2~ concentration in the blood. Therefore, if the E~2~ concentration in the blood can be controlled, TAI with PG effectiveness should improve. It is known that exogenous estrogens in cows can induce a preovulatory-like LH surge and ovulation \[[@r24]\]. The injection of estradiol benzoate (ODB) induces a peak concentration of serum estradiol, the magnitude of which is similar to natural estrus \[[@r33]\] and reproduces the LH surge \[[@r5], [@r9], [@r38], [@r41]\]. In this study, the anovulation rate was high, even though all ovulations occurred 4 days after PG treatment in Group D6. If a clear E~2~ peak could be created in anovulation cows, it might be possible to induce ovulation. The optimum timing of treatment with ODB is 20 to 24 hr after PG treatment when the CL is absent and endogenous P~4~ is less than 1 *n*g/m*l* \[[@r5], [@r38], [@r41]\]. Evans *et al*. reported that PG treatment on Day 10 to Day 13 and ODB administration 24 hr later shortens the time from PG treatment to peak E~2~ levels or the LH surge. Furthermore, all 2nd DFs ovulated 4 days after PG treatment \[[@r15]\].

Another practical way to improve TAI using PG is to administer PG to cows that have a CL in their ovaries \[[@r6]\], give artificial insemination (AI) 3 days after PG treatment, and then confirm ovulation on the day after AI. If the DFs have not ovulated, AI can be given again at this point. This method might cover the ovulation that occurs between 4--6 days after PG treatment, and in this study, ovulation occurred 4--6 days after PG treatment in 97.9% of ovulated cows. Otherwise, AI can be given 3 days after PG treatment. Then ovulation can be confirmed 2 days after AI. If the DFs have still not ovulated, AI can be given again at this point. This method might cover ovulations that occur between 4 to 7 days after AI.

In conclusion, the type of ovulatory follicle induced by PG treatment and the number of days from PG treatment to ovulation depend on the E~2~ secretion ability of the DF present at the time of PG treatment. When a DF can secrete enough E~2~ to induce the GnRH surge immediately after PG treatment, then that DF will ovulate 4 days after PG treatment. However, if the DF has already lost the ability to secrete E~2~, a new DF develops and ovulates 5 to 7 days after PG treatment. In addition, a possible cause of anovulation, despite regression of the CL after PG treatment, may be abnormal follicular E~2~ secretion.
